IL-33 is regulated by TNF-α in normal and psoriatic skin

Archives of Dermatological Research

Volumn 306, Issue 3, 2014, Pages 299-304

  Balato, Anna ^a   Di Caprio, Roberta ^a   Canta, Luigi ^a   Mattii, Martina ^a   Lembo, Serena ^a   Raimondo, Annunziata ^a   Schiattarella, Maria ^a   Balato, Nicola ^a   Ayala, Fabio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Anti TNF therapy; IL 33; Psoriasis; TNF

Indexed keywords

INTERLEUKIN 33; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EPIDERMIS; EX VIVO STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS;

ANTIBODIES, MONOCLONAL, HUMANIZED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; ORGAN CULTURE TECHNIQUES; PSORIASIS; RNA, MESSENGER; SKIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84898907041     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-014-1447-9     Document Type: Article

References (24)

1. Balato A, Schiattarella M, Lembo S, Mattii M, Prevete N, Balato N, Ayala F (2013) Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid. Arch Dermatol Res 305:255-262
2. Balato A, Lembo S, Mattii M, Schiattarella M, Marino R, De Paulis A, Balato N, Ayala F (2012) IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp Dermatol 21:892-894
3. Balato A, Schiattarella M, Di Caprio R, Lembo S, Mattii M, Balato N, Ayala F (2013) Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway. J Eur Acad Dermatol Venereol. doi: 10.1111/jdv.12240
4. Bonish B, Jullien D, Dutronc Y, Huang BB, Modlin R, Spada FM, Porcelli SA, Nickoloff BJ (2000) Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-γ production by NKT cells. J Immunol 165:4076-4085
5. Kempuraj D, Twait EC, Williard DE, Yuan Z, Meyerholz DK, Samuel I (2013) The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice. PLoS ONE 8:e56866
6. Kitano Y, Okada N (1983) Separation of the epidermal sheet by dispase. Br J Dermatol 108:555-560
7. Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T, Saito Y, Fujiyama Y, Andoh A (2010) Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol 45:999-1007
8. Kunisch E, Chakilam S, Gandesiri M, Kinne RW (2012) IL-33 regulates TNF-α dependent effects in synovial fibroblasts. Int J Mol Med 29:530-540
9. Lefrançais E, Cayrol C (2012) Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members. Eur Cytokine Netw 23:120-127
10. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 4:402-408
11. Masamune A, Watanabe T, Kikuta K, Satoh K, Kanno A, Shimosegawa T (2010) Nuclear expression of interleukin-33 in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 299:G821-G832
12. Mattii M, Ayala F, Balato N, Filotico R, Lembo S, Schiattarella M, Patruno C, Marone G, Balato A (2013) The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members. Exp Dermatol 22:813-819
13. Meephansan J, Komine M, Tsuda H, Karakawa M, Tominaga S, Ohtsuki M (2013) Expression of IL-33 in the epidermis: the mechanism of induction by IL-17. J Dermatol Sci 71:107-114
14. Meephansan J, Tsuda H, Komine M, Tominaga S, Ohtsuki M (2012) Regulation of IL-33 expression by IFN-γ and tumor necrosis factor-α in normal human epidermal keratinocytes. J Invest Dermatol 132:2593-2600
15. Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS ONE 6:e3331
16. Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemière C, Martin JG, Hamid Q (2009) Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 183:5094-5103
17. Pushparaj PN, Tay HK, H'ng SC, Pitman N, Xu D, McKenzie A, Liew FY (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 106:9773-9778
18. Ruifrok AC, Johnston DA (2001) Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23:291-299
19. Saidi S, Bouri F, Lencel P, Duplomb L, Baud'huin M, Delplace S, Leterme D, Miellot F, Heymann D, Hardouin P, Palmer G, Magne D (2011) IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling. Cytokine 53:347-354
20. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479-490
21. Seltmann J, Werfel T, Wittmann M (2013) Evidence for a regulatory loop between IFN-γ and IL-33 in skin inflammation. Exp Dermatol 22:102-107
22. Smithgall MD, Comeau MR, Yoon BP, Kaufman D, Armitage R, Smith DE (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen reactive Th2 cells, iNKT and NK Cells. Int Immunol 20:1019-1030
23. Trowell OA (1954) A modified technique for organ culture in vitro. Exp Cell Res 6:246-248
24. Wood IS, Wang B, Trayhurn P (2009) IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem Biophys Res Commun 384:105-109